(Q43556118)

24 November 2017

A United Kingdom coordinating committee on cancer research study of adjuvant chemotherapy for colorectal cancer: preliminary results (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

Kerr DJ

1

1 reference

24 November 2017

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

28

1 reference

24 November 2017

31-34

1 reference

24 November 2017

1 Suppl 1

1 reference

24 November 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Adjuvant therapy for cancer of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

A prospective randomized study comparing high- and low-dose leucovorin combined with same-dose 5-fluorouracil in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0093-7754%2801%2990249-0

7 January 2021

10.1016/S0093-7754(01)90249-0

Identifiers

DOI

1 reference

24 November 2017

1 reference

PubMed ID

11273587